Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3916)
All Articles published online
|
Oct 7, 2008 (publication date) through Nov 30, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Oki M, Yamamoto H, Taniguchi H, Adachi Y, Imai K, Shinomura Y. Overexpression of the receptor tyrosine kinase EphA4 in human gastric cancers. World J Gastroenterol 2008; 14(37): 5650-5656 [PMID: 18837080 DOI: 10.3748/wjg.14.5650] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i37/5650.htm |
| Number | Citing Articles |
| 1 |
Yilong Dong, Yang Liu, Aimei Jiang, Ruiqian Li, Min Yin, Yanmei Wang. MicroRNA-335 suppresses the proliferation, migration, and invasion of breast cancer cells by targeting EphA4. Molecular and Cellular Biochemistry 2018; 439(1-2): 95 doi: 10.1007/s11010-017-3139-1
|
| 2 |
Chen-Wei Chiang, Yun-Shih Lin, Fu-Ling Chang, Tsai-Yu Lin, Keng-Chang Tsai, Wei-Chun HuangFu, Yu-Ching Lee. Single-chain fragment antibody disrupting the EphA4 function as a therapeutic drug for gastric cancer. Biochemical and Biophysical Research Communications 2023; 680: 161 doi: 10.1016/j.bbrc.2023.09.025
|
| 3 |
Mona G. El-Sisi, Sara M. Radwan, Alia M. Saeed, Hala O. El-Mesallamy. Serum levels of FAK and some of its effectors in adult AML: correlation with prognostic factors and survival. Molecular and Cellular Biochemistry 2021; 476(5): 1949 doi: 10.1007/s11010-020-04030-z
|
| 4 |
Yuejun Sun, Jianzhong Qian, Min Lu, Hongming Xu. Lower and reduced expression of EphA4 is associated with advanced TNM stage, lymph node metastasis, and poor survival in breast carcinoma. Pathology International 2016; 66(9): 506 doi: 10.1111/pin.12444
|
| 5 |
Catarina Marques, Juliana Poças, Catarina Gomes, Isabel Faria-Ramos, Celso A. Reis, Romain R. Vivès, Ana Magalhães. Glycosyltransferases EXTL2 and EXTL3 cellular balance dictates heparan sulfate biosynthesis and shapes gastric cancer cell motility and invasion. Journal of Biological Chemistry 2022; 298(11): 102546 doi: 10.1016/j.jbc.2022.102546
|
| 6 |
Takuma Yamashita, Kiyohito Kato, Shintaro Fujihara, Hisakazu Iwama, Asahiro Morishita, Hiroki Yamana, Kiyoyuki Kobayashi, Hideki Kamada, Taiga Chiyo, Hideki Kobara, Kunihiko Tsutsui, Keiichi Okano, Yasuyuki Suzuki, Tsutomu Masaki. Anti-diabetic drug metformin inhibits cell proliferation and tumor growth in gallbladder cancer via G0/G1 cell cycle arrest. Anti-Cancer Drugs 2020; 31(3): 231 doi: 10.1097/CAD.0000000000000870
|
| 7 |
Su‐Hsi Lu, Yu‐Ling Chen, Chia‐Tung Shun, Jung‐Nien Lai, Shian‐Yang Peng, Po‐Lin Lai, Hey‐Chi Hsu. Expression and prognostic significance of gastric‐specific annexin A10 in diffuse‐ and intestinal‐type gastric carcinoma. Journal of Gastroenterology and Hepatology 2011; 26(1): 90 doi: 10.1111/j.1440-1746.2010.06480.x
|
| 8 |
Jean Defourny, Christiane Peuckert, Klas Kullander, Brigitte Malgrange. EphA4-ADAM10 Interplay Patterns the Cochlear Sensory Epithelium through Local Disruption of Adherens Junctions. iScience 2019; 11: 246 doi: 10.1016/j.isci.2018.12.017
|
| 9 |
Oscar J Buckens, Btissame El Hassouni, Elisa Giovannetti, Godefridus J Peters. The role of Eph receptors in cancer and how to target them: novel approaches in cancer treatment. Expert Opinion on Investigational Drugs 2020; 29(6): 567 doi: 10.1080/13543784.2020.1762566
|
| 10 |
Shintaro Uchiyama, Noritaka Saeki, Kazushige Ogawa. Aberrant EphB/ephrin-B expression in experimental gastric lesions and tumor cells. World Journal of Gastroenterology 2015; 21(2): 453-464 doi: 10.3748/wjg.v21.i2.453
|
| 11 |
Kohji Miyazaki, Mikito Inokuchi, Yoko Takagi, Keiji Kato, Kazuyuki Kojima, Kenichi Sugihara. EphA4 is a prognostic factor in gastric cancer. BMC Clinical Pathology 2013; 13(1) doi: 10.1186/1472-6890-13-19
|
| 12 |
L. Rhoda Molife, Emma Jane Dean, Montserrat Blanco-Codesido, Matthew G. Krebs, Andre T. Brunetto, Alastair Peter Greystoke, Gennaro Daniele, Lucy Lee, Galina Kuznetsov, Khin Than Myint, Karen Wood, Begoña de las Heras, Malcolm Richard Ranson. A Phase I, Dose-Escalation Study of the Multitargeted Receptor Tyrosine Kinase Inhibitor, Golvatinib, in Patients with Advanced Solid Tumors. Clinical Cancer Research 2014; 20(24): 6284 doi: 10.1158/1078-0432.CCR-14-0409
|
| 13 |
Devargya Ganguly, Joshua Abby Thomas, Abid Ali, Rahul Kumar. Mechanistic and therapeutic implications of EphA‐4 receptor tyrosine kinase in the pathogenesis of Alzheimer's disease. European Journal of Neuroscience 2022; 56(9): 5532 doi: 10.1111/ejn.15591
|
| 14 |
Xiuli Wu, Zhihao Liu, Cailin Gan, Wei Wei, Qianyu Zhang, Hongyao Liu, Hanyun Que, Xingping Su, Lin Yue, Hualong He, Liang Ouyang, Tinghong Ye. Design, synthesis and biological evaluation of a series of novel pyrrolo[2,3-d]pyrimidin/pyrazolo[3,4-d]pyrimidin-4-amine derivatives as FGFRs-dominant multi-target receptor tyrosine kinase inhibitors for the treatment of gastric cancer. Bioorganic Chemistry 2022; 127: 105965 doi: 10.1016/j.bioorg.2022.105965
|
| 15 |
Yang Lyu, Fuda Xie, Bonan Chen, Wing Sum Shin, Wei Chen, Yulong He, Kam Tong Leung, Gary M. K. Tse, Jun Yu, Ka Fai To, Wei Kang. The nerve cells in gastrointestinal cancers: from molecular mechanisms to clinical intervention. Oncogene 2024; 43(2): 77 doi: 10.1038/s41388-023-02909-x
|
| 16 |
Jia Chen, Xianming Zhang, Samantha Schaller, Theodore S. Jardetzky, Richard Longnecker, Thomas Shenk, Gary Cohen, Erle Robertson. Ephrin Receptor A4 is a New Kaposi’s Sarcoma-Associated Herpesvirus Virus Entry Receptor. mBio 2019; 10(1) doi: 10.1128/mBio.02892-18
|
| 17 |
Xiaoting Guo, Yanyi Yang, Jingqun Tang, Juanjuan Xiang. Ephs in cancer progression: complexity and context-dependent nature in signaling, angiogenesis and immunity. Cell Communication and Signaling 2024; 22(1) doi: 10.1186/s12964-024-01580-3
|
| 18 |
Julia E. Herrmann, Morgan A. Pence, Emanuel A. Shapera, Ravi R. Shah, Cédric G. Geoffroy, Binhai Zheng. Generation of an EphA4 conditional allele in mice. genesis 2010; 48(2): 101 doi: 10.1002/dvg.20587
|
| 19 |
Oscar P.J. van Linden, Carine Farenc, Willem H. Zoutman, Liesbeth Hameetman, Maikel Wijtmans, Rob Leurs, Cornelis P. Tensen, Gregg Siegal, Iwan J.P. de Esch. Fragment based lead discovery of small molecule inhibitors for the EPHA4 receptor tyrosine kinase. European Journal of Medicinal Chemistry 2012; 47: 493 doi: 10.1016/j.ejmech.2011.11.020
|
| 20 |
Ilias Nikas, Constantinos Giaginis, Kalliopi Petrouska, Paraskevi Alexandrou, Artemis Michail, Panagiotis Sarantis, Gerasimos Tsourouflis, Eugene Danas, Alexandros Pergaris, Panagiotis Politis, Lydia Nakopoulou, Stamatios Theocharis. EPHA2, EPHA4, and EPHA7 Expression in Triple-Negative Breast Cancer. Diagnostics 2022; 12(2): 366 doi: 10.3390/diagnostics12020366
|
| 21 |
Bei-bei Xu, En-dian Zheng, Hao-yue Sun, Yi Huang, Liang Zheng, Qiao-li Lan, Xiao-lu Zhou, Xiao-ge Geng, Ya-nan Wang, Xiu-yan Wang, Ying-cong Yu. Comprehensive analysis of circular RNA-associated competing endogenous RNA networks and immune infiltration in gastric cancer. Transplant Immunology 2023; 77: 101793 doi: 10.1016/j.trim.2023.101793
|
| 22 |
Ke Wang, Xin-hui Zhao, Jun Liu, Rui Zhang, Ji-peng Li. Nervous system and gastric cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020; 1873(1): 188313 doi: 10.1016/j.bbcan.2019.188313
|
| 23 |
Andrew W. Boyd, Perry F. Bartlett, Martin Lackmann. Therapeutic targeting of EPH receptors and their ligands. Nature Reviews Drug Discovery 2014; 13(1): 39 doi: 10.1038/nrd4175
|
| 24 |
Michael P Bova, Gene G Kinney. Emerging drug targets in amyotrophic lateral sclerosis. Expert Opinion on Orphan Drugs 2013; 1(1): 5 doi: 10.1517/21678707.2013.744949
|
| 25 |
S. A. Zozulya, I. P. Udovichenko. Eph family receptors as therapeutic targets. Russian Journal of Bioorganic Chemistry 2012; 38(3): 231 doi: 10.1134/S106816201203017X
|
| 26 |
昱洁 吴. Correlation Analysis between Gastric Cancer and FGFR3. Journal of Clinical Personalized Medicine 2024; 3(02): 229 doi: 10.12677/jcpm.2024.32034
|
| 27 |
Michael P Bova, Gene G Kinney. Emerging drug targets in amyotrophic lateral sclerosis. Expert Opinion on Orphan Drugs 2013; 1(1): 5 doi: 10.1517/21678707.2013.744949
|
| 28 |
CHENGLI LIU, HUI HUANG, CHENG WANG, YALIN KONG, HONGYI ZHANG. Involvement of ephrin receptor A4 in pancreatic cancer cell motility and invasion. Oncology Letters 2014; 7(6): 2165 doi: 10.3892/ol.2014.2011
|
| 29 |
Liesbeth Hameetman, Leslie van der Fits, Willem H. Zoutman, Jacoba J. Out-Luiting, Gregg Siegal, Iwan J.P. de Esch, Maarten H. Vermeer, Cornelis P. Tensen. EPHA4 is overexpressed but not functionally active in Sézary syndrome. Oncotarget 2015; 6(31): 31868 doi: 10.18632/oncotarget.5573
|
| 30 |
Ilaria Lamberto, Haina Qin, Roberta Noberini, Lakshmanane Premkumar, Caroline Bourgin, Stefan J. Riedl, Jianxing Song, Elena B. Pasquale. Distinctive binding of three antagonistic peptides to the ephrin-binding pocket of the EphA4 receptor. Biochemical Journal 2012; 445(1): 47 doi: 10.1042/BJ20120408
|
| 31 |
Emily J. Cabourne, Gretta Roberts, Robert Goldin, Timothy Ryder, Margaret Mobberly, Paul Ziprin. Investigation of Tumor–Peritoneal Interactions in the Pathogenesis of Peritoneal Metastases using a Novel Ex Vivo Peritoneal Model1. Journal of Surgical Research 2010; 164(2): e265 doi: 10.1016/j.jss.2010.09.041
|
| 32 |
Thomas Gaitanos, Irina Dudanova, Maria Sakkou, Rüdiger Klein, Sónia Paixão. Receptor Tyrosine Kinases: Family and Subfamilies. 2015; : 165 doi: 10.1007/978-3-319-11888-8_5
|
| 33 |
Alexandros Pergaris, Eugene Danas, Dimitrios Goutas, Alexandros G. Sykaras, Angelos Soranidis, Stamatios Theocharis. The Clinical Impact of the EPH/Ephrin System in Cancer: Unwinding the Thread. International Journal of Molecular Sciences 2021; 22(16): 8412 doi: 10.3390/ijms22168412
|
| 34 |
Stamatios Theocharis, Jerzy Klijanienko, Constantinos Giaginis, Paraskevi Alexandrou, Efstratios Patsouris, Xavier Sastre-Garau. Ephrin Receptor (Eph) -A1, -A2, -A4 and -A7 Expression in Mobile Tongue Squamous Cell Carcinoma: Associations with Clinicopathological Parameters and Patients Survival. Pathology & Oncology Research 2014; 20(2): 277 doi: 10.1007/s12253-013-9692-3
|
| 35 |
Chaochao Xu, Wulan Li, Peihong Qiu, Yiqun Xia, Xiaojing Du, Fen Wang, Lailai Shen, Qiuxiang Chen, Yunjie Zhao, Rong Jin, Jianzhang Wu, Guang Liang, Xiaokun Li. The therapeutic potential of a novel non-ATP-competitive fibroblast growth factor receptor 1 inhibitor on gastric cancer. Anti-Cancer Drugs 2015; 26(4): 379 doi: 10.1097/CAD.0000000000000195
|
| 36 |
E. S. Grigorieva, Yu. A. Bukurova, G. S. Krasnov, S. G. Afanas’ev, N. V. Cherdyntseva, S. A. Tuzikov, E. L. Choinzonov, V. L. Karpov, N. A. Lisitsyn, S. F. Beresten. Identification of proteins overexpressed in malignant gastric tumors: Comparison of results obtained by 2DE and bioinformatic search. Molecular Biology 2011; 45(4): 680 doi: 10.1134/S0026893311030058
|
| 37 |
|
| 38 |
Xiaofeng Han, Yan Xu, Yilei Yang, Jingle Xi, Wang Tian, Srinivas Duggineni, Ziwei Huang, Jing An, Jie Zheng. Discovery and Characterization of a Novel Cyclic Peptide That Effectively Inhibits Ephrin Binding to the EphA4 Receptor and Displays Anti-Angiogenesis Activity. PLoS ONE 2013; 8(11): e80183 doi: 10.1371/journal.pone.0080183
|
| 39 |
Haihui Lu, Karl R. Clauser, Wai Leong Tam, Julia Fröse, Xin Ye, Elinor Ng Eaton, Ferenc Reinhardt, Vera S. Donnenberg, Rohit Bhargava, Steven A. Carr, Robert A. Weinberg. A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages. Nature Cell Biology 2014; 16(11): 1105 doi: 10.1038/ncb3041
|
| 40 |
Jun Zeng, Kai Ran, Xinyue Li, Longyue Tao, Qiwei Wang, Jiangtao Ren, Rong Hu, Yongxia Zhu, Zhihao Liu, Luoting Yu. A novel small molecule RK-019 inhibits FGFR2-amplification gastric cancer cell proliferation and induces apoptosis in vitro and in vivo. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.998199
|
| 41 |
HIDEAKI MURASE, MIKITO INOKUCHI, YOKO TAKAGI, KEIJI KATO, KAZUYUKI KOJIMA, KENICHI SUGIHARA. Prognostic significance of the co-overexpression of fibroblast growth factor receptors 1, 2 and 4 in gastric cancer. Molecular and Clinical Oncology 2014; 2(4): 509 doi: 10.3892/mco.2014.293
|
| 42 |
Marina Leite, Miguel S. Marques, Joana Melo, Marta T. Pinto, Bruno Cavadas, Miguel Aroso, Maria Gomez-Lazaro, Raquel Seruca, Ceu Figueiredo. Helicobacter Pylori Targets the EPHA2 Receptor Tyrosine Kinase in Gastric Cells Modulating Key Cellular Functions. Cells 2020; 9(2): 513 doi: 10.3390/cells9020513
|
| 43 |
Constantinos Giaginis, Gerasimos Tsourouflis, Adamantia Zizi-Serbetzoglou, Gregorios Kouraklis, Elli Chatzopoulou, Konstantina Dimakopoulou, Stamatios E. Theocharis. Clinical Significance of Ephrin (Eph)-A1, -A2, -A4, -A5 and -A7 Receptors in Pancreatic Ductal Adenocarcinoma. Pathology & Oncology Research 2010; 16(2): 267 doi: 10.1007/s12253-009-9221-6
|
| 44 |
Jessica E. Lisle, Inga Mertens-Walker, Raphael Rutkowski, Adrian C. Herington, Sally-Anne Stephenson. Eph receptors and their ligands: Promising molecular biomarkers and therapeutic targets in prostate cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2013; 1835(2): 243 doi: 10.1016/j.bbcan.2013.01.003
|
| 45 |
Alessandra Cecchini, D. D. W. Cornelison. Eph/Ephrin-Based Protein Complexes: The Importance of cis Interactions in Guiding Cellular Processes. Frontiers in Molecular Biosciences 2022; 8 doi: 10.3389/fmolb.2021.809364
|
| 46 |
Pierre Saintigny, Shaohua Peng, Li Zhang, Banibrata Sen, Ignacio I. Wistuba, Scott M. Lippman, Luc Girard, John D. Minna, John V. Heymach, Faye M. Johnson. Global Evaluation of Eph Receptors and Ephrins in Lung Adenocarcinomas Identifies EphA4 as an Inhibitor of Cell Migration and Invasion. Molecular Cancer Therapeutics 2012; 11(9): 2021 doi: 10.1158/1535-7163.MCT-12-0030
|
| 47 |
Ilaria Lamberto, Bernhard C. Lechtenberg, Erika J. Olson, Peter D. Mace, Philip E. Dawson, Stefan J. Riedl, Elena B. Pasquale. Development and Structural Analysis of a Nanomolar Cyclic Peptide Antagonist for the EphA4 Receptor. ACS Chemical Biology 2014; 9(12): 2787 doi: 10.1021/cb500677x
|
| 48 |
Dhayalan Pavithra, Kesavan Sabitha, Thangarajan Rajkumar. Identification of small molecule inhibitors for differentially expressed miRNAs in gastric cancer. Computational Biology and Chemistry 2018; 77: 442 doi: 10.1016/j.compbiolchem.2018.07.013
|